253 related articles for article (PubMed ID: 17254027)
1. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
Hunter RL; Dragicevic N; Seifert K; Choi DY; Liu M; Kim HC; Cass WA; Sullivan PG; Bing G
J Neurochem; 2007 Mar; 100(5):1375-86. PubMed ID: 17254027
[TBL] [Abstract][Full Text] [Related]
2. The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.
Swanson CR; Joers V; Bondarenko V; Brunner K; Simmons HA; Ziegler TE; Kemnitz JW; Johnson JA; Emborg ME
J Neuroinflammation; 2011 Aug; 8():91. PubMed ID: 21819568
[TBL] [Abstract][Full Text] [Related]
3. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
Pinto M; Nissanka N; Peralta S; Brambilla R; Diaz F; Moraes CT
Mol Neurodegener; 2016 Apr; 11():25. PubMed ID: 27038906
[TBL] [Abstract][Full Text] [Related]
5. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration.
Chinta SJ; Kumar MJ; Hsu M; Rajagopalan S; Kaur D; Rane A; Nicholls DG; Choi J; Andersen JK
J Neurosci; 2007 Dec; 27(51):13997-4006. PubMed ID: 18094238
[TBL] [Abstract][Full Text] [Related]
6. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
[TBL] [Abstract][Full Text] [Related]
7. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.
Ramsey CP; Tansey MG
Exp Neurol; 2014 Jun; 256():126-32. PubMed ID: 23726958
[TBL] [Abstract][Full Text] [Related]
8. Age-associated sex difference in the expression of mitochondria-based redox sensitive proteins and effect of pioglitazone in nonhuman primate brain.
Jamwal S; Blackburn JK; Elsworth JD
Biol Sex Differ; 2023 Sep; 14(1):65. PubMed ID: 37770961
[TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes.
Binukumar BK; Bal A; Kandimalla RJ; Gill KD
Mol Brain; 2010 Nov; 3():35. PubMed ID: 21073741
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological targeting of β
O'Neill E; Yssel JD; McNamara C; Harkin A
Br J Pharmacol; 2020 Jan; 177(2):282-297. PubMed ID: 31506926
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats.
Yeh JH; Wang KC; Kaizaki A; Lee JW; Wei HC; Tucci MA; Ojeda NB; Fan LW; Tien LT
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208374
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective potential of saroglitazar in 6-OHDA induced Parkinson's disease in rats.
Bhatt R; Vaishnav D; Airao V; Sharma T; Rachamalla M; Mani S; Gupta AK; Upadhye V; Jha SK; Jha NK; Parmar S
Chem Biol Drug Des; 2023 Nov; 102(5):955-971. PubMed ID: 37518817
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss.
Song DY; Yu HN; Park CR; Lee JS; Lee JY; Park BG; Woo RS; Han JT; Cho BP; Baik TK
BMC Neurosci; 2013 Oct; 14():112. PubMed ID: 24093518
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.
Tansey MG; McCoy MK; Frank-Cannon TC
Exp Neurol; 2007 Nov; 208(1):1-25. PubMed ID: 17720159
[TBL] [Abstract][Full Text] [Related]
15. Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease.
Srivastava P; Nishiyama S; Lin SH; Srivastava A; Su C; Peng W; Levy M; Schwarzschild M; Xu Y; Chen X
Res Sq; 2023 Jun; ():. PubMed ID: 37398302
[TBL] [Abstract][Full Text] [Related]
16. CREB Inactivation by HDAC1/PP1γ Contributes to Dopaminergic Neurodegeneration in Parkinson's Disease.
Xu X; He X; Zhang Z; Chen Y; Li J; Ma S; Huang Q; Li M
J Neurosci; 2022 Jun; 42(22):4594-4604. PubMed ID: 35501151
[TBL] [Abstract][Full Text] [Related]
17. Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
Carta AR; Pisanu A; Carboni E
Parkinsons Dis; 2011; 2011():689181. PubMed ID: 21603186
[TBL] [Abstract][Full Text] [Related]
18. Preserved striatal innervation maintains motor function despite severe loss of nigral dopaminergic neurons.
Paß T; Ricke KM; Hofmann P; Chowdhury RS; Nie Y; Chinnery P; Endepols H; Neumaier B; Carvalho A; Rigoux L; Steculorum SM; Prudent J; Riemer T; Aswendt M; Liss B; Brachvogel B; Wiesner RJ
Brain; 2024 Apr; ():. PubMed ID: 38574200
[TBL] [Abstract][Full Text] [Related]
19. Mild pentachlorophenol-mediated uncoupling of mitochondria depletes ATP but does not cause an oxidized redox state or dopaminergic neurodegeneration in
Markovich ZR; Hartman JH; Ryde IT; Hershberger KA; Joyce AS; Ferguson PL; Meyer JN
Curr Res Toxicol; 2022; 3():100084. PubMed ID: 35957653
[TBL] [Abstract][Full Text] [Related]
20. Myelin Basic Protein and Cardiac Sympathetic Neurodegeneration in Nonhuman Primates.
Metzger JM; Matsoff HN; Vu D; Zinnen AD; Jones KM; Bondarenko V; Simmons HA; Moore CF; Emborg ME
Neurol Res Int; 2021; 2021():4776610. PubMed ID: 34646580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
